Welcome
Support Centre
30 July 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised controlled trial to evaluate the effectiveness of a pharmacist's telephone reminders in reducing mortality in patients receiving polypharmacy
ISRCTN ISRCTN48076318
ClinicalTrials.gov identifier
Public title A randomised controlled trial to evaluate the effectiveness of a pharmacist's telephone reminders in reducing mortality in patients receiving polypharmacy
Scientific title
Acronym N/A
Serial number at source HSRC/HCPF226103
Study hypothesis To investigate the effects of compliance and periodic telephone counselling by a pharmacist on mortality in patients receiving polypharmacy.
Ethics approval Added as of 22/10/2007:
Ethics approval received from the Chinese University of Hong Kong clinical research ethics committee.
Study design Randomised controlled trial
Countries of recruitment Hong Kong
Disease/condition/study domain Compliance to polypharmacy
Participants - inclusion criteria Patients receiving polypharmacy defined as five or more chronic medications who were found to be non-compliant upon first assessment by pharmacist
Participants - exclusion criteria 1. Speak non-Cantonese dialects or a different language
2. Conditions that prevented effective communication (for example, patients who are deaf, mute, or have dementia or other psychological disorders)
3. Live in nursing homes with supervised treatment
Anticipated start date 01/10/1998
Anticipated end date 01/06/1999
Status of trial Completed
Patient information material
Target number of participants Added as of 22/10/2007: 502 recruited
Interventions Patients randomised to the intervention group received a 10 - 15 minute telephone call from the pharmacist for education and counselling between clinic visits for 2 years. Patients in the control group did not receive any telephone reminders.
Primary outcome measure(s) Time from randomisation to death from any cause.
Secondary outcome measure(s) 1. Changes in the rate of admission to hospital
2. Number of emergency room visits
3. Hospital stay in the two years before and after the screening visit
4. Changes in compliance
Sources of funding Hong Kong SAR Government Health Services Research Committee (Hong Kong)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/pubmed/16916809
Contact name Prof  Juliana CN  Chan
  Address Dept of Medicine and Therapeutics
Chinese University of Hong Kong
The Prince of Wales Hospital
Shatin
  City/town -
  Zip/Postcode -
  Country Hong Kong
  Tel +852 (0)2632 3138
  Fax +852 (0)2632 3108
  Email jchan@cuhk.edu.hk
Sponsor Hong Kong Health Services Research Fund (Hong Kong)
  Address Health Welfare and Food Bureau
Government Secretariat, HKSAR
20th floor Murray Building
Garden Road
  City/town -
  Zip/Postcode -
  Country Hong Kong
  Tel +852 (0)2973 8288
  Fax +852 (0)2869 4376
  Email hsrf@hwfb.gov.hk
  Sponsor website: http://www.fhb.gov.hk/index.html
Date applied 05/10/2004
Last edited 18/02/2008
Date ISRCTN assigned 15/02/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central